Navigation Links
New Phase IV Clinical Study Indicates LidoSite Provides,Rheumatology Patients Superior Pain Relief

ver possible. In fact, the APS and AAP agree that acute pain experienced with medical procedures can, in most cases, be substantially reduced and even prevented.

The use of iontophoresis to deal with pain associated with skin punctures (e.g. injections, blood draws etc) is supported by the Blue Cross/Blue Shield Technical Evaluation Center, indicating that "use of iontophoresis to administer local anesthetic before skin puncture or dermal procedures meets the TEC criteria."(1) Various Blue Cross/Blue Shield plans, providing care to over 50 million Americans, have issued a medical policy to its thousands of physician providers supporting the TEC findings and indicating "iontophoresis may be considered medically necessary to administer local anesthesia prior to venipuncture or dermal procedures."(2)

About the Clinical Study

On behalf of Vyteris, the clinical study was conducted by INC Research, a therapeutically focused contract research organization with an unrivaled reputation for conducting global clinical development programs including a complete range of customized Phase 1 - Phase 4 programs in therapeutic areas of specialty, and in innovative pediatric trials. INC Research is headquartered in Raleigh, North Carolina, and in 22 locations in 35 countries worldwide. For more information, please visit www.incresearch.com.

About Vyteris, Inc.

Vyteris, Inc., a wholly owned subsidiary of Vyteris Holdings (Nevada), Inc. (OTCBB: VYHN), are the makers of the first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration (FDA). Vyteris' proprietary active transdermal drug delivery (iontophoresis) technology delivers drugs comfortably through the skin using low-level electrical energy. This active patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that can result in considerable therapeutic, economical, and lifestyle adv
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:
(Date:11/9/2009)...ewswire/ -- Women,s sexual health company, TivaMed...e as it prepares for a 2010 launch of its Viveve s...veve is a name that we believe captures the essenc...said Kerry Pope, Viveve,s president and chief exec...ing women restore their sense of fulfillment and s...
(Date:11/9/2009)...swire/ -- Access MediQuip, LLC, the nation,s first...dical device management solutions to the healthcar...its corporate headquarters to Lake Mary, Florida. ...growth, includes a major expansion of the Primera ...uary 2010 and relocation and expansion of the Hous...
(Date:11/9/2009)...wire/ -- Decision Resources, one of the world,s le...al and healthcare issues, finds that, in 2008, hum...ting therapies -- which include Roche/Chugai,s Her...Tyverb -- were the highest-selling drug class in b...tin and Tykerb/Tyverb and the expected launches of...
Breaking Medicine Technology:Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2American Medical Experts Offers New Reduced Flat Rates for Complete Case Reviews 28 24695 29 and Expert Witness Reports 28 24995 29 49705 1American Medical Experts Offers New Reduced Flat Rates for Complete Case Reviews 28 24695 29 and Expert Witness Reports 28 24995 29 49705 2American Medical Experts Offers New Reduced Flat Rates for Complete Case Reviews 28 24695 29 and Expert Witness Reports 28 24995 29 49705 3American Medical Experts Offers New Reduced Flat Rates for Complete Case Reviews 28 24695 29 and Expert Witness Reports 28 24995 29 49705 4Patients Spent an Average of Four Hours and Three Minutes in U S Emergency Departments in 2008 According to Latest Press Ganey Report 49699 1Patients Spent an Average of Four Hours and Three Minutes in U S Emergency Departments in 2008 According to Latest Press Ganey Report 49699 2Patients Spent an Average of Four Hours and Three Minutes in U S Emergency Departments in 2008 According to Latest Press Ganey Report 49699 3Patients Spent an Average of Four Hours and Three Minutes in U S Emergency Departments in 2008 According to Latest Press Ganey Report 49699 4Patients Spent an Average of Four Hours and Three Minutes in U S Emergency Departments in 2008 According to Latest Press Ganey Report 49699 5Patients Spent an Average of Four Hours and Three Minutes in U S Emergency Departments in 2008 According to Latest Press Ganey Report 49699 6Patients Spent an Average of Four Hours and Three Minutes in U S Emergency Departments in 2008 According to Latest Press Ganey Report 49699 7Patients Spent an Average of Four Hours and Three Minutes in U S Emergency Departments in 2008 According to Latest Press Ganey Report 49699 8Fruit fly steps in to fight human disease 12735 1Fruit fly steps in to fight human disease 12735 2
...EW YORK, Dec. 3 Sangamo BioSciences, Inc.,(Nasdaq... an update on milestones,achieved in 2008 and prev...,and Analyst Briefing to be held in New York City ...a-Aldrich Corporation,s Research,Biotech Business ...ial of the,two companies, collaboration to commerc...
...EWARK, Del., Dec. 3 Isogen, a contract developmen...ng, announced it has retained a,strategic financia... global,biopharma demand for Isogen,s services. , ... first round series of capital,investment and the ...009 to,deliver on the previously unmet process, fa...
Other Medicine Technology:Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 4Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 5Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 6Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3
(Date:11/9/2009)...,, CAMBRIDGE, Mass., Nov. 9 A...nd capabilities in delivering emergency management...ly awarded contracts to support the work of the Fe...of Regional Operations, the National Commission on...litan Area Transit Authority (WMATA). The value o...
(Date:11/9/2009)...,, WASHINGTON, Nov. 9 /PRNewswire-USNewswire/ -...PA), representing more than 75,000 clinically prac...e United States, applauds the U.S. House of Repres...orm bill, H.R. 3962, the Affordable Health Care fo...that this reform bill will ultimately lower the co...
(Date:11/9/2009)... This release is available in French . , ,... came in twos: male and female. In human bodies tr...molecules from which they are composed. Yet these...tinguishable clusters. Because these complex cell ...ientists have long searched for ways to splice cel...
(Date:11/9/2009)... As many as 10 million people around the world su...niversity in Frankfurt and his coauthors discuss c...cial lens in the current issue of Deutsches rzteb...[43]: 695�). , Blindness is usually due t...e than 600,000 cataract operations are performed e...
(Date:11/9/2009)... (Washington, DC) Physician bias might be the rea.../pancreas transplants at the same rate as similar ...on, director of kidney and pancreas transplantatio...professor of surgery at Georgetown University Medi... in the November issue of the American Journal of...
Breaking Medicine News(10 mins):Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:Physician bias might keep life-saving transplants from black and Hispanic patients 2
...ks the cradle rules the world! Rightly so, for a m...the moment of birth. //Enabling the child with the...wishful-thinking, and in this age of information, ...l endeavor to celebrate the inherent wholesomeness...
...tment of Health has announced that the efforts mad...abies have been successful //and more and more mot... The department's Senior Medical and Health Offi...ve breastfeeding. The numbers for mothers who ever...
...developed by Dr. Edward A. Hirschowitz and Dr. Li ...s in people who are at high risk for developing th... cancer death in United States and around the worl...ever, the blood test being developed at the Univer...
...ecent study has shown that married couples, who lo...e after an eventuality, would most //often seek th...f a survey conducted amongst 298 people. It... a child for assistance showed a greater preferenc...
...ound that different genes may be involved in causi... that other genes may also be involved //in the ea...rder in a new study published in the online editio...r Gerard Schellenberg, a researcher at the Puget S...
...atoshi Kanazawa who led the research at the London...are 26% more likely //to have a daughter than a so...al attractiveness is heritable and because daughte...epends largely on status and women’s on the youth ...
Other Medicine News:Health News:Breast Milk: The Mother of All Milk for Infants 2Health News:Breast Milk: The Mother of All Milk for Infants 3Health News:New Blood Test For Early Detection Of Lung Cancer 2Health News:New Findings on Autism Research 2
...offered as 1-piece or modular, in regular or extra...omized with handles of choice and other options su...tandard patterns are available from Mediflex stock...s. , Please Note: Individual instrument componen...
...offered as 1-piece or modular, in regular or extra...omized with handles of choice and other options su...tandard patterns are available from Mediflex stock...s. , Please Note: Individual instrument componen...
...offered as 1-piece or modular, in regular or extra...omized with handles of choice and other options su...tandard patterns are available from Mediflex stock...s. , Please Note: Individual instrument componen...
...offered as 1-piece or modular, in regular or extra...omized with handles of choice and other options su...tandard patterns are available from Mediflex stock...s. , Please Note: Individual instrument componen...
Medicine Products: